Home / For clinicians / Conditions / Hepatology
Hepatology: rare disease drugs and conditions
Not a doctor or health care professional? This page is for clinicians.Go to the patient version
2 conditions and 2 prescribing guides so far.
By specialty and condition
Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials.
Prescribing guides
The first 90 days from the prescriber's side, built from the current label, the drugmaker's program and one public insurer policy.
Primary biliary cholangitis (PBC)
Livdelzi (seladelpar)Dosing, Liver Monitoring, Interactions, PANo REMS; baseline clinical and laboratory liver assessment, a check for decompensated cirrhosis, a medication review against the interaction table, prior authorization, and routing to a specialty pharmacy in Gilead's network.Wilson disease
Cuvrior (trientine tetrahydrochloride)Penicillamine Conversion, NCC and PANo REMS and no boxed warning; confirm stable, de-coppered Wilson disease tolerant to penicillamine, convert the penicillamine dose by Table 1, discontinue penicillamine before day 1, and send the Navigator Start Form or an eRx to PANTHERx Rare, the only dispensing pharmacy.